[1]. Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2026年) [査読] 有
[DOI] [2]. Survey of the Current status and Challenges of Centralized Review in Multicenter Research in Japan.
Journal of empirical research on human research ethics : JERHRE [頁]15562646261441433 (2026年) [査読] 有
[3]. 小規模体制で大規模な遠隔同意取得に挑む -浜松医科大学医学部附属病院におけるeConsent導入実践報告-
臨床薬理 [巻]56 [号]5 [頁]218 -225 (2025年) [査読] 有
[4]. Immunosuppressive Therapy for Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases: Insights from Japanese Registry
ADVANCES IN THERAPY [巻]42 [頁]6103 -6117 (2025年) [査読] 有
[DOI] [5]. The Efficacy and Safety of Outpatient Exercise Training for Patients with Chronic Thromboembolic Pulmonary Hypertension After Balloon Pulmonary Angioplasty.
Journal of cardiovascular development and disease [巻]12 [号]6 (2025年) [査読] 有